Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

OSUR vs DBVT vs IQV vs ALKS vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OSUR
OraSure Technologies, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$225M
5Y Perf.-78.5%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
IQV
IQVIA Holdings Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$30.32B
5Y Perf.+19.5%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-78.6%

OSUR vs DBVT vs IQV vs ALKS vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OSUR logoOSUR
DBVT logoDBVT
IQV logoIQV
ALKS logoALKS
PRGO logoPRGO
IndustryMedical - Instruments & SuppliesBiotechnologyMedical - Diagnostics & ResearchBiotechnologyDrug Manufacturers - Specialty & Generic
Market Cap$225M$1712.35T$30.32B$5.90B$1.61B
Revenue (TTM)$85M$0.00$16.63B$1.56B$4.18B
Net Income (TTM)$-53M$-168M$1.39B$153M$-1.82B
Gross Margin38.8%26.1%65.4%34.2%
Operating Margin-58.6%13.9%12.3%-4.1%
Forward P/E14.1x24.8x5.6x
Total Debt$13M$22M$16.17B$70M$3.97B
Cash & Equiv.$199K$194M$1.98B$1.12B$532M

OSUR vs DBVT vs IQV vs ALKS vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OSUR
DBVT
IQV
ALKS
PRGO
StockMay 20May 26Return
OraSure Technologie… (OSUR)10021.5-78.5%
DBV Technologies S.… (DBVT)10041.2-58.8%
IQVIA Holdings Inc. (IQV)100119.5+19.5%
Alkermes plc (ALKS)100216.4+116.4%
Perrigo Company plc (PRGO)10021.4-78.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: OSUR vs DBVT vs IQV vs ALKS vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ALKS leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Perrigo Company plc is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. DBVT and IQV also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
OSUR
OraSure Technologies, Inc.
The Healthcare Pick

Among these 5 stocks, OSUR doesn't own a clear edge in any measured category.

Best for: healthcare exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT ranks third and is worth considering specifically for momentum.

  • +110.4% vs PRGO's -51.2%
Best for: momentum
IQV
IQVIA Holdings Inc.
The Growth Play

IQV is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 5.9%, EPS growth 4.7%, 3Y rev CAGR 4.2%
  • 166.5% 10Y total return vs ALKS's -11.0%
  • 5.9% revenue growth vs DBVT's -100.0%
Best for: growth exposure and long-term compounding
ALKS
Alkermes plc
The Defensive Pick

ALKS carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.

  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.06, current ratio 3.55x
  • 9.8% margin vs OSUR's -61.9%
  • Beta 1.06 vs OSUR's 1.45, lower leverage
Best for: sleep-well-at-night and defensive
PRGO
Perrigo Company plc
The Income Pick

PRGO is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • Lower P/E (5.6x vs 24.8x)
  • 9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthIQV logoIQV5.9% revenue growth vs DBVT's -100.0%
ValuePRGO logoPRGOLower P/E (5.6x vs 24.8x)
Quality / MarginsALKS logoALKS9.8% margin vs OSUR's -61.9%
Stability / SafetyALKS logoALKSBeta 1.06 vs OSUR's 1.45, lower leverage
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs PRGO's -51.2%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

OSUR vs DBVT vs IQV vs ALKS vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OSUROraSure Technologies, Inc.
FY 2025
Product And Services
94.8%$109M
Other Revenues
5.2%$6M
DBVTDBV Technologies S.A.

Segment breakdown not available.

IQVIQVIA Holdings Inc.
FY 2025
Research And Development Solutions
54.5%$8.9B
Technology And Analytics Solutions
40.6%$6.6B
Contract Sales And Medical Solutions
4.8%$788M
ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

OSUR vs DBVT vs IQV vs ALKS vs PRGO — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGIQV

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 4 of 6 comparable metrics.

IQV and DBVT operate at a comparable scale, with $16.6B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to OSUR's -61.9%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOSUR logoOSUROraSure Technolog…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$85M$0$16.6B$1.6B$4.2B
EBITDAEarnings before interest/tax-$45M-$112M$3.5B$212M$58M
Net IncomeAfter-tax profit-$53M-$168M$1.4B$153M-$1.8B
Free Cash FlowCash after capex-$33M-$151M$2.7B$392M$108M
Gross MarginGross profit ÷ Revenue+38.8%+26.1%+65.4%+34.2%
Operating MarginEBIT ÷ Revenue-58.6%+13.9%+12.3%-4.1%
Net MarginNet income ÷ Revenue-61.9%+8.3%+9.8%-43.5%
FCF MarginFCF ÷ Revenue-38.9%+16.1%+25.1%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year-99.9%+8.4%+28.2%-7.2%
EPS Growth (YoY)Latest quarter vs prior year-52.4%+91.5%+15.0%-4.1%-56.4%
ALKS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 5 of 6 comparable metrics.

At 22.8x trailing earnings, IQV trades at a 8% valuation discount to ALKS's 24.8x P/E. On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than ALKS's 17.3x.

MetricOSUR logoOSUROraSure Technolog…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Market CapShares × price$225M$1712.35T$30.3B$5.9B$1.6B
Enterprise ValueMkt cap + debt − cash$238M$1712.35T$44.5B$4.9B$5.1B
Trailing P/EPrice ÷ TTM EPS-3.33x-0.76x22.79x24.76x-1.14x
Forward P/EPrice ÷ next-FY EPS est.14.06x5.56x
PEG RatioP/E ÷ EPS growth rate0.56x
EV / EBITDAEnterprise value multiple12.97x17.25x7.42x
Price / SalesMarket cap ÷ Revenue1.96x1.86x4.00x0.38x
Price / BookPrice ÷ Book value/share0.67x0.66x4.67x3.28x0.55x
Price / FCFMarket cap ÷ FCF14.78x12.28x11.12x
PRGO leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 7 of 9 comparable metrics.

IQV delivers a 22.1% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to IQV's 2.44x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs OSUR's 3/9, reflecting strong financial health.

MetricOSUR logoOSUROraSure Technolog…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity-15.1%-130.2%+22.1%+8.8%-50.7%
ROA (TTM)Return on assets-12.8%-89.0%+4.7%+5.4%-19.8%
ROICReturn on invested capital-20.0%+8.7%+18.9%+3.7%
ROCEReturn on capital employed-16.8%-145.7%+11.0%+14.2%+4.3%
Piotroski ScoreFundamental quality 0–934474
Debt / EquityFinancial leverage0.04x0.13x2.44x0.04x1.35x
Net DebtTotal debt minus cash$13M-$172M$14.2B-$1.0B$3.4B
Cash & Equiv.Liquid assets$199,278$194M$2.0B$1.1B$532M
Total DebtShort + long-term debt$13M$22M$16.2B$70M$4.0B
Interest CoverageEBIT ÷ Interest expense-189.82x3.10x32.30x-7.20x
ALKS leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricOSUR logoOSUROraSure Technolog…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date+31.5%+4.9%-20.7%+25.3%-13.5%
1-Year ReturnPast 12 months+12.2%+110.4%+16.5%+16.5%-51.2%
3-Year ReturnCumulative with dividends-55.2%+19.7%-5.9%+14.5%-58.1%
5-Year ReturnCumulative with dividends-68.3%-69.1%-23.8%+60.9%-60.1%
10-Year ReturnCumulative with dividends-53.1%-87.0%+166.5%-11.0%-77.7%
CAGR (3Y)Annualised 3-year return-23.5%+6.2%-2.0%+4.6%-25.2%
DBVT leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than OSUR's 1.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOSUR logoOSUROraSure Technolog…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5001.45x1.26x1.33x1.06x1.18x
52-Week HighHighest price in past year$3.82$26.18$247.05$36.60$28.44
52-Week LowLowest price in past year$2.08$7.53$134.65$25.17$9.23
% of 52W HighCurrent price vs 52-week peak+81.9%+76.3%+72.3%+96.7%+41.2%
RSI (14)Momentum oscillator 0–10047.148.158.560.260.9
Avg Volume (50D)Average daily shares traded473K252K1.6M2.3M3.4M
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: OSUR as "Hold", DBVT as "Buy", IQV as "Buy", ALKS as "Buy", PRGO as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44). PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.

MetricOSUR logoOSUROraSure Technolog…DBVT logoDBVTDBV Technologies …IQV logoIQVIQVIA Holdings In…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuyHold
Price TargetConsensus 12-month target$4.00$46.33$225.63$44.00$20.00
# AnalystsCovering analysts1315442836
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises202010
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap+6.7%0.0%+4.1%+0.5%0.0%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallAlkermes plc (ALKS)Leads 3 of 6 categories
Loading custom metrics...

OSUR vs DBVT vs IQV vs ALKS vs PRGO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is OSUR or DBVT or IQV or ALKS or PRGO a better buy right now?

For growth investors, IQVIA Holdings Inc.

(IQV) is the stronger pick with 5. 9% revenue growth year-over-year, versus -38. 1% for OraSure Technologies, Inc. (OSUR). IQVIA Holdings Inc. (IQV) offers the better valuation at 22. 8x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OSUR or DBVT or IQV or ALKS or PRGO?

On trailing P/E, IQVIA Holdings Inc.

(IQV) is the cheapest at 22. 8x versus Alkermes plc at 24. 8x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — OSUR or DBVT or IQV or ALKS or PRGO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: IQV returned +166. 5% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OSUR or DBVT or IQV or ALKS or PRGO?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

06β versus OraSure Technologies, Inc. 's 1. 45β — meaning OSUR is approximately 37% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 2% for IQVIA Holdings Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — OSUR or DBVT or IQV or ALKS or PRGO?

By revenue growth (latest reported year), IQVIA Holdings Inc.

(IQV) is pulling ahead at 5. 9% versus -38. 1% for OraSure Technologies, Inc. (OSUR). On earnings-per-share growth, the picture is similar: IQVIA Holdings Inc. grew EPS 4. 7% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OSUR or DBVT or IQV or ALKS or PRGO?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -59. 8% for OraSure Technologies, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -59. 2% for OSUR. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OSUR or DBVT or IQV or ALKS or PRGO more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 14. 1x for IQVIA Holdings Inc. — 8. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — OSUR or DBVT or IQV or ALKS or PRGO?

In this comparison, PRGO (9.

8% yield) pays a dividend. OSUR, DBVT, IQV, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is OSUR or DBVT or IQV or ALKS or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

18), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, OSUR: -53. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OSUR and DBVT and IQV and ALKS and PRGO?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: OSUR is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; IQV is a mid-cap quality compounder stock; ALKS is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while OSUR, DBVT, IQV, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

OSUR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

IQV

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.